Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
Noor ZaidanJoseph Patrik HornakDavid ReynosoPublished in: Antimicrobial agents and chemotherapy (2021)
Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.
Keyphrases
- drug resistant
- acinetobacter baumannii
- multidrug resistant
- septic shock
- gram negative
- klebsiella pneumoniae
- randomized controlled trial
- case report
- respiratory failure
- community acquired pneumonia
- type diabetes
- quality improvement
- staphylococcus aureus
- skeletal muscle
- weight loss
- extracorporeal membrane oxygenation